Clinical Trial Update: Microvessels and Heart Problems in Sickle Cell Disease

View source ↗

Summary

NHLBI-sponsored clinical trial investigating microvessel and heart problems in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease | Status: COMPLETED